[
  {
    "ts": "2025-05-19T13:26:34+00:00",
    "headline": "FDA approves Incyte’s retifanlimab combo for SCAC treatment",
    "summary": "The regulator’s priority review and sBLA approval of the antibody were supported by data from Phase III and Phase II trials.",
    "url": "https://www.pharmaceutical-technology.com/news/incyte-retifanlimab-combo/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "0b08016d-8753-32ac-a185-fda114b7ff9b",
      "content": {
        "id": "0b08016d-8753-32ac-a185-fda114b7ff9b",
        "contentType": "STORY",
        "title": "FDA approves Incyte’s retifanlimab combo for SCAC treatment",
        "description": "",
        "summary": "The regulator’s priority review and sBLA approval of the antibody were supported by data from Phase III and Phase II trials.",
        "pubDate": "2025-05-19T13:26:34Z",
        "displayTime": "2025-05-19T13:26:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/3981ca70cf46b660c5a2f630e38c42f9",
          "originalWidth": 1440,
          "originalHeight": 960,
          "caption": "Incyte markets the antibody in the US. Credit: JHVEPhoto/Shutterstock.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uvqjDyxhQ_LAXfsm32ZGKA--~B/aD05NjA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/3981ca70cf46b660c5a2f630e38c42f9.cf.webp",
              "width": 1440,
              "height": 960,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vfAGTLX4mQpB9nHEEckeLw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/3981ca70cf46b660c5a2f630e38c42f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/incyte-retifanlimab-combo/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-approves-incyte-retifanlimab-combo-132634153.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]